The Briefing: Skechers, TikTok, and Khaby Lame: Is Barrett Wissman Potentially Liable?
The LathamTECH Podcast — Trade Secrets: The New Litigation Battleground
Podcast: Williams Mullen's Trending Now - An IP Podcast - When AI Meets Art: Litigation and Settlement Trends Affecting Artists
The Briefing: Vetter v. Resnik: When Copyright Termination Goes Global
IP Goes Pop! S7 Ep 1- We’re #1! Intellectual Property Firsts
Why Won't the USPTO Register My Last Name? — No Infringement Intended Podcast
The Briefing: Kat Von D, Miles Davis, and the Possible Death of the Intrinsic Test?
2026 Trends to Watch: Regulation, Infrastructure and IP in Motion
'Desk Drawer Roundup': NIL Contract Fights, Eligibility Battles, and the CSC Participation Agreement — Highway to NIL Podcast
The Briefing: Part Two: CCPA’s New Rules on Risk Assessments and Cybersecurity Audits
The Briefing: Part One: CCPA’s New Rules on Automated Decision making Technology (ADMT)
We get AI for work™: New Efforts to Ensure a National AI Policy
The Briefing: Why Lady Gaga Beat a Trademark Injunction Over “Mayhem”
Beyond the Deals: Student-Athlete Identity, Development, and NIL With 42U's Stephen Bienko — Highway to NIL Podcast
The Privacy Insider Podcast Episode 22: The Data Privacy of the Dead & Critiquing the Digital Divine with Carl Öhman of Uppsala University
Why Does Everyone Say 'The Big Game' Instead of 'Super Bowl'? — No Infringement Intended Podcast
The Briefing: Top Gun Cleared for Takeoff: The Ninth Circuit Affirms Paramount’s Copyright Win
The Briefing: The 2026 Forecast: Resolving Some of the Entertainment Industry’s Open Legal Issues
The Briefing: 2025 IP Resolutions Start With a Review of IP Assets (Featured)
Wolf Greenfield Attorneys Review 2025 and Look Ahead to 2026
Patent attorneys spend a lot of time explaining two deceptively simple concepts: novelty and obviousness. Both rise and fall on one thing: prior art. Most inventors assume prior art means a patent or some obscure technical...more
Estate planning is often viewed as a process that ends at death, with assets transferred and administration completed through probate or trust administration. For many forms of intellectual property, however, that view is...more
Welcome to Blank Rome Appellate Insights: Winning on Appeal, a newsletter dedicated to keeping you informed about the latest developments in appellate law. Each issue will provide thought leadership from our appellate...more
The Supreme Court of the United States on March 2, 2026, denied certiorari in Thaler v. Perlmutter, leaving intact the D.C. Circuit's ruling that the Copyright Act requires copyrightable works to be authored by a human being....more
Kilpatrick’s Betsy Bengtson, Darin Brown, and Andrea LaFrance recently presented “A Trademark Practitioner’s Guide to Using AI: Guidelines, Use Cases, and Ethical Considerations” during the firm’s annual “SKI-LE” in...more
In Genuine Enabling Technology LLC v. Sony Group Corporation, decided February 19, 2026, the United States Court of Appeals for Federal Circuit affirmed a district court’s grant of summary judgment of non-infringement: a...more
On February 27, 2026, the U.S. Department of Justice’s Antitrust Division and the U.S. Patent and Trademark Office filed a Statement of Interest in Collision Communications, Inc. v. Samsung Electronics Co., Ltd., pending in...more
The Federal Circuit has issued a nonprecedential decision in Rensselaer Polytechnic Institute, CF Dynamic Advances LLC v. Amazon.com, Inc., relating to U.S. Patent No. 7,177,798 (the “798 patent”) to Rensselaer Polytechnic...more
A recent final determination in Investigation No. 337-TA-1400 issued by the US International Trade Commission (ITC) may have some clients saying, “I don’t always seek ITC enforcement. But when I do, I prefer to include a...more
The Federal Court of Australia has delivered a landmark decision in McCallum v Projector Films, finding that general moral rights waivers for copyright works are not enforceable. The decision follows an urgent...more
Welcome to our quarterly update relating to biologics and biosimilars, including post-grant and patent litigation challenges to blockbuster biologics. Since the enactment of the Biologics Price Competition and Innovation Act...more
Generative AI is now embedded in development, marketing, post, and distribution—but the legal rules are still being written in real time. This program surveys the 2026 battleground issues: copyright (training vs. outputs),...more
A California federal court denied Elon Musk’s X.AI request to block enforcement of the state’s AI training data transparency law, rejecting the company’s claims that the disclosure requirements would destroy trade secrets and...more
A consequence of the gradual decline in COVID infections worldwide has been a less gradual increase in patent litigation by the many entities having patent rights for the vaccines or components of them. This is particularly...more
In a closely watched case regarding copyright protection for AI-created works, on March 2, 2026, the Supreme Court of the United States declined to grant review in Thaler v. Perlmutter (Case No. 25-449). In denying...more
A Florida appellate panel on Friday blocked a lower court's temporary injunction giving an extra year of eligibility for a college basketball player, ruling in a split opinion that the order's findings weren't sufficient to...more
In Fish & Richardson’s 2025 biologics and biosimilars review, we cover Food and Drug Administration (FDA) approvals, new biosimilar launches, Biologics Price Competition and Innovation Act (BPCIA) litigation and other...more
In Sanas.AI Inc. v. Krisp Technologies, Inc., Chief Judge Richard Seeborg of the U.S. District Court for the Northern District of California denied Krisp's Rule 12(c) motion challenging five Sanas patents on accent...more
Etanercept Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple...more
In Dusome v. Canada (Attorney General), 2025 FC 1809, the Federal Court reviewed the Commissioner of Patents' decision refusing to grant Canadian Patent Application Number 2,701,028 on the basis that it was a “mere scientific...more
FDA recently published a new draft Guidance for Industry titled “New Clinical Investigation Exclusivity (3-Year Exclusivity) for Drug Products: Questions and Answers” (Mar. 2026) (the “Draft Guidance”). The Draft Guidance...more
Part one of this series highlighted the historic high that trade secret litigation hit in 2025 with more than 1,550 cases filed in courts across the United States and suggested proactive, common-sense steps that businesses...more
Fusion power can potentially provide the world with safe, clean, and renewable power. As recent advances in superconducting magnet fabrication and AI-enabled field optimization propel stellarators from academic endeavors...more
The University of Alabama in Huntsville (UAH) and aerospace company ASKA have agreed to explore collaboration on a drive-and-fly aircraft. The proposed joint development exemplifies the need for careful consideration of...more
A case currently before the Trademark Trial and Appeal Board (“TTAB”) has the potential to significantly widen the scope of trademark dilution protection by allowing companies to point to past success as evidence of current...more